Heramed Ltd
Research Heramed Ltd (HMD) on Bullrun: market cap AUD 43.98M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHMD
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryMedical Devices
- CurrencyAUD
- Market capAUD 43.98M
- Financial periodFY2025
- RevenueAUD 293.38K
- Revenue growth-19.5%
- Net income-AUD 4.13M
- Free cash flow-AUD 3.66M
- Gross margin100.0%
Valuation Snapshot
latest market cap is AUD 43.98M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 293.38K | -AUD 4.13M | -AUD 3.66M | 100.0% | 0 | AUD 1.37M | AUD 282.39K | AUD 931.03K |
| FY2024 | AUD 364.33K | -AUD 5.49M | -AUD 4.81M | 60.0% | -0.01 | AUD 3.13M | AUD 815.96K | AUD 2.77M |
| FY2023 | AUD 591.36K | -AUD 6.61M | -AUD 5.57M | 60.0% | -0.02 | AUD 1.06M | AUD 307.31K | AUD 685.01K |
| FY2022 | AUD 321.79K | -AUD 7.17M | -AUD 4.78M | 64.2% | -0.03 | AUD 3.85M | AUD 261.87K | AUD 4.21M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | AUD 43.98M | n/a | n/a | n/a |
About Heramed Ltd
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women's health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Heramed Ltd's market cap?
Heramed Ltd's market capitalization is AUD 43.98M.
What does Heramed Ltd do?
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women's health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.